Fluiter K, van der Westhuijzen D R, van Berkel T J
Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, University of Leiden, Sylvius Laboratories, P. O. Box 9503, 2300 RA Leiden, The Netherlands.
J Biol Chem. 1998 Apr 3;273(14):8434-8. doi: 10.1074/jbc.273.14.8434.
High density lipoprotein cholesteryl esters (HDL-CE) are selectively taken up by liver parenchymal cells without parallel apolipoprotein uptake. This selective uptake route forms an important step in the so-called reverse cholesterol transport. Scavenger receptor BI (SR-BI) is the only known HDL receptor which can mediate selective uptake of HDL-CE. In the present study we investigated its regulation in liver cells. The down-regulation of SR-BI expression in liver by 17alpha-ethinyl estradiol (EE) treatment was found by immunoblotting to be the consequence of down-regulation of SR-BI in parenchymal cells, while SR-BI expression in Kupffer cells was up-regulated. The selective uptake of HDL-CE in vivo by parenchymal and Kupffer cells was measured by labeling of HDL with [3H]CE and analysis of the cellular uptake at 10 min after injection. After EE treatment, uptake of [3H]CE-labeled HDL by parenchymal cells decreased by 85%, while Kupffer cells showed a 4-fold increase in selective uptake of [3H]CE-labeled HDL. In vitro studies with isolated parenchymal cells indicated that after EE treatment, the selective uptake of [3H]CE labeled HDL was 3-4-fold lower, indicating that the in vivo observations are also reflected in vitro. A 2-week high-cholesterol diet leads to lowering of SR-BI expression in parenchymal cells, while the expression in Kupffer cells is increased. Like EE treatment, the selective uptake of [3H]CE-labeled HDL by the two hepatic cell types in vivo correlated with the changes in expression of SR-BI. Our results thus demonstrate that within the liver, the regulation of SR-BI expression by EE treatment or a high-cholesterol diet, correlates with changes in the selective uptake of HDL-CE, supporting a function of SR-BI to mediate the selective uptake of HDL-CE in the liver parenchymal cells. The contrasting regulatory effect on parenchymal cells and Kupffer cells might indicate a different function of SR-BI in the latter cell type.
高密度脂蛋白胆固醇酯(HDL-CE)被肝实质细胞选择性摄取,而载脂蛋白的摄取并不与之平行。这种选择性摄取途径是所谓逆向胆固醇转运中的重要一步。清道夫受体BI(SR-BI)是唯一已知的能够介导HDL-CE选择性摄取的HDL受体。在本研究中,我们调查了其在肝细胞中的调节情况。通过免疫印迹发现,经17α-乙炔雌二醇(EE)处理后,肝脏中SR-BI表达的下调是实质细胞中SR-BI下调的结果,而枯否细胞中SR-BI的表达上调。通过用[3H]CE标记HDL并在注射后10分钟分析细胞摄取情况,来测定实质细胞和枯否细胞在体内对HDL-CE的选择性摄取。EE处理后,实质细胞对[3H]CE标记的HDL的摄取减少了85%,而枯否细胞对[3H]CE标记的HDL的选择性摄取增加了4倍。对分离的实质细胞进行的体外研究表明,EE处理后,[3H]CE标记的HDL的选择性摄取降低了3至4倍,表明体内观察结果在体外也得到了体现。为期2周的高胆固醇饮食会导致实质细胞中SR-BI表达降低,而枯否细胞中的表达增加。与EE处理一样,体内两种肝细胞类型对[3H]CE标记的HDL的选择性摄取与SR-BI表达的变化相关。因此,我们的结果表明,在肝脏内,EE处理或高胆固醇饮食对SR-BI表达的调节与HDL-CE选择性摄取的变化相关,支持SR-BI在肝实质细胞中介导HDL-CE选择性摄取的功能。对实质细胞和枯否细胞的相反调节作用可能表明SR-BI在后者细胞类型中的功能不同。